8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 3, 2008

DATASCOPE CORP.

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of incorporation)	0-6516 (Commission File Number)	13-2529596 (IRS Employer Identification No.)
14 Philips Parkway Montvale, New Jersey (Address of principal executive offices)		07645-9998 (Zip Code)

(Registrant’s telephone number, including area code): (201) 391-8100

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. Other Events

     On January 3, 2008, the Corporation issued a press release announcing that the independent inspector of elections, IVS Associates, Inc. (“IVS”), has certified the preliminary voting results from the Company’s 2007 Annual Meeting of Shareholders held on December 20, 2007. Based on the final tabulation and certification by IVS, Datascope shareholders re-elected James J. Loughlin and elected Dr. David Dantzker, who ran as a shareholder nominee. The Company also announced today that it has named Mr. Loughlin as lead independent director of the Board of Directors. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.

     The information, including Exhibit 99.1, furnished in this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information in this Form 8-K shall not be incorporated by reference into any filing under the Securities Act of 1933, except as shall otherwise be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits:

          Exhibit 99.1 Press release announcing certified voting results for the 2007 Annual Meeting of Shareholders.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

DATASCOPE CORP.

Registrant

/s/ Henry M. Scaramelli

  Vice President, Finance and

  Chief Financial Officer

Dated: January 4, 2008

EXHIBIT INDEX

Exhibit No.	Description
99.1	Press release announcing certified voting results for the 2007 Annual Meeting of Shareholders.

EX-99.1

Exhibit No. 99.1

FOR IMMEDIATE RELEASE

DATASCOPE ANNOUNCES CERTIFIED VOTING RESULTS FOR
2007 ANNUAL MEETING OF SHAREHOLDERS

MONTVALE, NJ, January 3, 2008 — Datascope Corp. (NASDAQ: DSCP) today announced that the independent inspector of elections, IVS Associates, Inc., has certified the preliminary voting results from the Company’s 2007 Annual Meeting of Shareholders held on December 20, 2007. Based on the final tabulation and certification by IVS, Datascope shareholders re-elected James J. Loughlin and elected Dr. David Dantzker, who ran as a shareholder nominee. The Company also announced today that it has named Mr. Loughlin as lead independent director of the Board of Directors.

Lawrence Saper, Chairman and CEO of Datascope, said, “On behalf of Datascope’s Board and management team, I thank all of our shareholders for their continued support and confidence throughout this proxy process.”

Mr. Saper added, “I would also like to thank Bill Asmundson for his invaluable contributions and dedication to Datascope and its shareholders since joining the Board in 1969, before the Company went public. We are pleased that Jim Loughlin, who has chaired our Audit Committee since he joined the Board in 2004, has accepted his new position as lead independent director.”

About Datascope Corp.

Datascope Corp. is the global leader of intra-aortic balloon counterpulsation, a pioneer and leader in the global patient monitoring market and a diversified medical device company that develops, manufactures and markets proprietary products for clinical health care markets in interventional cardiology and radiology, cardiovascular and vascular surgery, anesthesiology, emergency medicine and critical care. The Company’s products are sold throughout the world through direct sales representatives and independent distributors. Founded in 1964, Datascope is headquartered in Montvale, New Jersey. For news releases, webcasts and other Company information please visit Datascope’s website, http://www.datascope.com.

# # #

Contact:
Matthew Sherman / Michael Cuneo
Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449

Larry Dennedy / Joseph Doherty
MacKenzie Partners, Inc.
(212) 929-5500